13-15 December 2017

24Days
8Hours
0Mins
0Secs

Abstract Submission Deadline2017-8-15

ISCO welcomes abstracts from all areas of treatment, nursing, basic sciences and translational research in SOLID TUMORS.

POSTER SUBMISSION DEADLINE2017-9-20

After passing of abstract submission deadline for oral presentations, we just accept abstracts for poster presentation.

Register Submission Deadline2017-10-25

Iranian Clinical Oncology congress is designed to improve cancer care in Iran, so it has CME credits for all specialties who involved in cancer care.

Registration

Program

This conference run through all 3 days from 13 - 15 December 2017.
We also provide free lunch and coffee break in each day.
Day 1
Day 2
Day 3
Main Hall

Opening Ceremony

First session (General oncology)

9:00 – 9:30: Immuno-oncology a new way in treatment of cancer
9:30 – 10: New approval immunotherapy in treatment of cancer (breast, lung, skin, head&neck, GI, GU and GYN cancers)
10 – 10:30: Panel: Cancer and health economy issue?

Read More

Café break

Second session (Breast cancer)

  • 10:50 – 11:10: Neoadjuvant Chemotherapy in early breast cancer; useful for whom?
  • 11:10 – 11:30: Extent of surgery post neoadjuvant chemotherapy (breast and axilla); minimal or extensive?
  • 11:30-11:50: Post-mastectomy radiation therapy after breast reconstruction (Indication, timing and results)
  • 11:50 – 12:10: Partial breast Irradiation; for whom and which technique?
Read More

Panel

  • Treatment options in patients with early breast cancer and BRCA mutation or family history of cance
    • Genetic consult
    • Surgical options
    • Systemic therapy
    • Fertility issues
    • Conclusions and clinical perspectives
Read More

First session (GU cancer)

8:30 – 8:50: Treatment choices in RCC: considering prognostic scoring, efficacy & safety & sequencing

8:50 – 9:10: Neoadjuvant Vs adjuvant therapy in muscle invasive bladder cancer

9:10 – 9:30: Treatment of Metastatic Castration-Sensitive/-Naïve Prostate Cancer

9:30 – 10:30: Panel Treatment of oligo-metastatic PCa

Read More

Café break

Second session (GYN and Head & Neck cancer)

10:50 – 11:10: Brachytherapy in gynecology cancer

11:10 – 11:30: Debate; Neoadjuvant chemotherapy versus primary radiochemotherapy in FIGO IB2 cervical cancer

11:30 – 11:50: Intraperitoneal, hyperthermic intraperitoneal and HIPEC chemotherapy

11:50 – 12:10: Strategies for patients with ovarian cancer who have received multiple prior therapies

12:10 – 13:20: Panel: Management of locally advance ovarian cancer

Read More

First session (Metastasis)

8:30 – 8:50: Metastasectomy for whom and when?

8:50 – 9:10: Non surgical Ablation therapy in metastatic patients

9:10 – 9:30: SBRT for metastases

9:30 -9:50: Primary tumor treatment instead of unresectable metastatic disease for which tumor?

9:50 – 10:30: Panel; case discussion (Patients with Unresectable Metastatic Cancer

Read More

Café break

Second session (GI cancer)

10:50 – 11:10: Gastric cancer (Patient with Gastric Cancer with + Peritoneal Cytology on Preop Laparoscopy—Palliate or Operate?

11:10 – 11:30: Pancreatic cancer ; Adjuvant or neoadjuvant chemoradiation in resectable pancreatic cancer

11:30 – 11:50: Rectal cancer; watch and wait policy in clinical complete response after neoadjuvant chemoradiation; the gains and pitfalls

11:50 – 12:10: Metastatic colorectal cancer Debate; Standard Chemotherapy or Targeted Approaches?

12:10 – 13:20: Panel; What is the best curative treatment strategy for a patient with synchronous rectal cancer and liver limited metastases?

Read More

Olympic Hotel Conference Hall

Olympic Hotel Conference Hall
Tehran, Bolvar-e-Gharbi-e-Stadium-e-Azadi

Recent News